• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Clin Virol. Emergent 2009 influenza A(H1N1) viruses containing HA D222N mutation associated with severe clinical outcomes in the Americas

Giuseppe

Emeritus
[Source: Journal of Clinical Virology, full text: (LINK). Abstract, edited.]


Journal of Clinical Virology

In Press, Corrected Proof - Note to users
doi:10.1016/j.jcv.2011.09.004
Permissions & Reprints


Emergent 2009 influenza A(H1N1) viruses containing HA D222N mutation associated with severe clinical outcomes in the Americas<SUP>☆</SUP>


Huo-Shu H. Houng<SUP>a</SUP>, Jason Garner<SUP>b</SUP><SUP>, </SUP><SUP>c</SUP>, Yanfei Zhou<SUP>a</SUP>, Arthur Lyons<SUP>a</SUP>, Robert Kuschner<SUP>a</SUP>, Gregory Deye<SUP>a</SUP>, Kristina St. Clair<SUP>d</SUP>, Richard W. Douce<SUP>e</SUP>, Wilson Chicaiza<SUP>e</SUP>, Patrick J. Blair<SUP>f</SUP>, Christopher A. Myers<SUP>f</SUP>, Ronald L. Burke<SUP>g</SUP>, Jose L. Sanchez<SUP>c, </SUP><SUP>g</SUP>, Maya Williams<SUP>h</SUP>, Eric S. Halsey<SUP>h</SUP>


<SUP>a) </SUP>Walter Reed Army Institute of Research, Silver Spring, MA 20910, USA ? <SUP>b) </SUP>United States Air Force School of Aerospace Medicine, Brooks City-Base, TX 78235, USA ? <SUP>c) </SUP>Henry M. Jackson Foundation for the Advancement of Military Medicine, Rockville, MA 20852, USA ? <SUP>d) </SUP>National Naval Medical Center, Bethesda, MA 20889, USA ? <SUP>e) </SUP>Hospital Vozandes Quito, Casilla 0691, Quito, Ecuador, USA ? <SUP>f) </SUP>Navy Health Research Center, San Diego, CA 92106, USA ? <SUP>g) </SUP>Armed Forces Health Surveillance Center, Global Emerging Infections Surveillance and Response System, Silver Spring, MA 20904, USA ? <SUP>h) </SUP>United States Naval Medical Research Unit Six, Lima, Peru 20521-3230, USA

Received 25 May 2011; revised 2 September 2011; Accepted 7 September 2011. Available online 28 October 2011.


Abstract

Background

During the 2010?2011 influenza season, a small sub-group of 2009 influenza A(H1N1) viruses (hereafter referred to as 2009 A(H1N1)) emerged that was associated with more severe clinical outcomes in Ecuador and North America. Genetically, the haemagglutinin (HA) of this sub-clade was distinct from HAs found in viruses associated with severe outbreaks in 2010 from the United Kingdom and from other global specimens isolated earlier in the season.


Objective

We report the emergence of a novel 2009 A(H1N1) variant possessing a re-emergent HA D222N mutation obtained from patients with severe respiratory illnesses and phylogenetically characterise these D222N mutants with other severe disease-causing variants clustering within a common emerging sub-clade.


Case reports

In early 2011, three cases of 2009 A(H1N1) infection, two from Quito, Ecuador, and one from Washington, DC, USA, were complicated by severe pneumonia requiring mechanical ventilation, resulting in one fatality. These cases were selected due to the reported nature of the acute respiratory distress (ARD) that were captured in Department of Defence (DoD)-sponsored global influenza surveillance nets.


Results

Genetically, the 2009 A(H1N1) strains isolated from two of the three severe cases carried a prominent amino acid change at position 222 (D222N) within the primary HA receptor binding site. Furthermore, these cases represent an emerging sub-clade of viruses defined by amino acid changes within HA: N31D, S162N, A186T and V272I. Phylogenetically, these viruses share a high degree of homology with strains associated with recent fatal cases in Chihuahua, Mexico.


Discussion

Previously, enhanced virulence associated with the change, D222G, has been clinically linked to severe morbidity and mortality. Initial observations of the prevalence of a novel sub-clade of strains in the Americas suggest that viruses with a re-emergent D222N mutation may too correlate with severe clinical manifestations. These findings warrant heightened vigilance for emerging sub-clades of 2009 A(H1N1) and presumptive clinical implications.

Keywords: 2009 A(HINI); Influenza; Severe infections; D222N; HA receptor binding site
- ------
 
Back
Top Bottom